Heptanoic acid,6-hydroxy-6-methyl-,decahydro-3,7-dihydroxy-11-(4-methoxyphenyl)-5,8-epoxy-5H-(1,5)dioxecino(3,2-b)pyrrol-6-yl ester
139159-00-5
|
AB-729
2634739-74-3
|
ab-bis(cyclopentadienyl)-c-(μ-chloro)-d-(μ-neohexylidene)-ef-diisobutylzirconium(IV)aluminium
79061-88-4
|
AB-506
2245020-50-0
|
AB-FUBINACA metabolite 3 (MMB-FUBINACA metabolite 1)
1877243-60-1
|
AB-MECA
152918-26-8
|
AB-FUBINACA
1185282-01-2
|
AB-452
2226178-35-2
|
AB-836
2445597-31-7
|
3-(6-methoxy[1,2,4]triazolo[4,3-b]pyridazin-3-yl)-N-(1,3-thiazol-2-yl)propanamide
1324067-19-7
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
[(3,5-Dichlorophenyl)methyl](2-methylbutan-2-yl)amine
1178293-35-0
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
N-(2-hydroxy-2-phenylpropyl)adamantane-1-carboxamide
1351585-08-4
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
